Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Doctor's hands in green medical gloves examine an umbilical hernia in a child, close-up.
    Clinical Trials

    Prolacta’s Human Milk Diet Enhances Recovery for Gastroschisis Infants

    May 16th, 2024

    ⁤Prolacta Bioscience announced data on the benefits of its Exclusive Human Milk Diet (EHMD) for term infants recovering from gastroschisis repair surgery at the ESPGHAN meeting in Milan. ⁤⁤Gastroschisis, a birth defect causing intestines to protrude through the abdominal wall, requires high macronutrient intake for recovery. [...]

Latest Stories

HEOR

RWE

Market Access

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

05/16/2024 04:48 PM ET

Avenue Therapeutics ATXI date announcement

Now that the Phase 1/2 trial of AJ201 is completed, Avenue Therapeutics will announce their top-line results on June 30, 2024. As of now, the drug has a 65.1% chance of moving on.

While investors [...]

Read More
05/16/2024 04:48 PM ET

Dermata Therapeutics BYSI results announcement

BeyondSpring has released new information on their trial for RBM39 degrader. Our analysts provided the following summary:

"IND planned for early 2025."

Investors were pleased with the news, but not enough to significantly [...]

Read More
05/16/2024 04:48 PM ET

Ascendis Pharma A/S ASND date announcement

Ascendis Pharma A/S already had ten catalyst announcements coming up, but they added another one today. It has an announcement scheduled for May 23, 2024 regarding their recent Approved trial of Breyanzi (lisocabtagene maraleucel) - [...]

Read More
05/16/2024 04:48 PM ET

Eyenovia IONS date announcement

After specifying an announcement date for BIIB105 (ATXN2 ASO) - (ALSpire) trial results, Ionis Pharmaceuticals now has nine catalyst announcements planned. On August 31, 2024, Ionis Pharmaceuticals will announce top-line results for their recent Phase [...]

Read More

Search HealthEconomics.com

Throw in a keyword, research topic, disease model or technology of interest

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Quick Links

Our Company

Privacy Policy

Advertising & Marketing Services


ABOUT US

HealthEconomics.com is the world’s largest digital Connected Community™ for Value, Evidence and Access in the life sciences industry. HealthEconomics.com provides professionals within the health economic and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) communities a single global link to industry insights and news, market reports and more. Since the beginning, we have provided unparalleled access to help our stakeholders drive business, improve knowledge and connect researchers and payer decision-makers worldwide.

SCIENTIST.COM FAMILY

Scientist.com is a privately-held, San Diego-based company on a mission to empower and connect scientists and make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace for complex research experiments with the potential to transform the pharmaceutical industry in the same way Amazon has transformed the retail industry. The marketplace helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Scientist.com’s clients include most of the world’s largest pharmaceutical companies, 100+ biotechs and the US National Institutes of Health. Through Scientist.com, these clients communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments.

Learn more at Scientist.com.

© Copyright | HealthEconomics.Com - A Scientist.com Company | All Rights Reserved
LinkedInTwitterFacebookVimeo
Cookies help us deliver our services and optimize website experience. By continuing to browse this domain, you accept our terms and conditions and privacy policy. Read our privacy policy Accept
Go to Top